Literature DB >> 12790804

Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus.

H Watanabe1, A Suzuki, M Kobayashi, E Takahashi, M Itamoto, D B Lubahn, H Handa, T Iguchi.   

Abstract

In order to understand early events caused by estrogen in vivo, temporal uterine gene expression profiles at early stages were examined using DNA microarray analysis. Ovariectomized mice were exposed to 17beta-estradiol and the temporal mRNA expression changes of ten thousand various genes were analyzed. Clustering analysis revealed that there are at least two phases of gene activation during the period up to six hours. One involved immediate-early genes, which included certain transcription factors and growth factors as well as oncogenes. The other involved early-late genes, which included genes related to RNA and protein synthesis. In clusters of down-regulated genes, transcription factors, proteases, apoptosis and cell cycle genes were found. These hormone-inducible genes were not induced in estrogen receptor (ER) alpha knockout mice. Although expression of ERbeta is known in the uterus, these findings indicate the importance of ERalpha in the changes in gene expression in the uterus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790804     DOI: 10.1677/jme.0.0300347

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  19 in total

1.  Estrogen induces distinct patterns of microRNA expression within the mouse uterus.

Authors:  Warren B Nothnick; Caitlin Healy
Journal:  Reprod Sci       Date:  2010-08-18       Impact factor: 3.060

2.  Nucleolar Sik-similar protein (Sik-SP) is required for the maintenance of uterine estrogen signaling mechanism via ERα.

Authors:  Daesuk Chung; Fei Gao; Alicia Ostmann; Xiaonan Hou; Sanjoy K Das
Journal:  Mol Endocrinol       Date:  2012-01-26

3.  Bip is a molecular link between the phase I and phase II estrogenic responses in uterus.

Authors:  Sanhita Ray; Xiaonan Hou; Han-E Zhou; Haibin Wang; Sanjoy K Das
Journal:  Mol Endocrinol       Date:  2006-03-30

4.  Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens.

Authors:  Toshi Shioda; Jessica Chesnes; Kathryn R Coser; Lihua Zou; Jingyung Hur; Kathleen L Dean; Carlos Sonnenschein; Ana M Soto; Kurt J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

5.  Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensing.

Authors:  Haiyan Pan; Yan Deng; Jeffrey W Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

6.  Cooperative control via lymphoid enhancer factor 1/T cell factor 3 and estrogen receptor-alpha for uterine gene regulation by estrogen.

Authors:  Sanhita Ray; Fuhua Xu; Haibin Wang; Sanjoy K Das
Journal:  Mol Endocrinol       Date:  2008-01-17

7.  Rapid recruitment of temporally distinct vascular gene sets by estrogen.

Authors:  Katrin K Schnoes; Iris Z Jaffe; Lakshmanan Iyer; Alexandra Dabreo; Mark Aronovitz; Brenna Newfell; Ulla Hansen; Giuseppe Rosano; Michael E Mendelsohn
Journal:  Mol Endocrinol       Date:  2008-09-11

8.  Early histone modifications in the ventromedial hypothalamus and preoptic area following oestradiol administration.

Authors:  K Gagnidze; Z M Weil; L C Faustino; S M Schaafsma; D W Pfaff
Journal:  J Neuroendocrinol       Date:  2013-10       Impact factor: 3.627

9.  Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus.

Authors:  Angela M Davis; Jiude Mao; Bushra Naz; Jessica A Kohl; Cheryl S Rosenfeld
Journal:  J Mol Endocrinol       Date:  2008-07-16       Impact factor: 5.098

Review 10.  Mechanisms of uterine estrogen signaling during early pregnancy in mice: an update.

Authors:  I Robertshaw; F Bian; S K Das
Journal:  J Mol Endocrinol       Date:  2016-02-17       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.